This inventor holds 1 USPTO granted patent. Top assignee: American Cyanamid Company. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Innovations of Feng Ling Qing in Retinoid Research
Introduction
Feng Ling Qing is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel analogs of retinoids. His work focuses on addressing critical health issues, such as coronary artery disease and atherosclerosis.
Latest Patents
Feng Ling Qing holds 1 patent for his invention titled "Restricted 9-cis retinoids." This invention presents novel analogs of 9-cis-retinoic acid, which are beneficial for the treatment and prevention of coronary artery disease. The analogs work by increasing HDL levels, thereby offering protection against premature atherosclerosis. The patent also includes processes for preparing these innovative 9-cis-retinoic acid analogs.
Career Highlights
Feng Ling Qing is associated with the American Cyanamid Company, where he has been able to apply his expertise in retinoid research. His work has contributed to advancements in pharmaceutical applications, particularly in cardiovascular health.
Collaborations
Feng Ling Qing has collaborated with notable professionals in his field, including Joseph William Epstein and Gary H. Birnberg. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Feng Ling Qing's contributions to the field of retinoid research exemplify the importance of innovation in addressing significant health challenges. His work continues to pave the way for advancements in medical treatments.